Clinical Trials
4 trialsNCT02184416 2026-02-27
ADONIS
Pfizer
Completed
NCT02264665 2023-11-13
OPALINE
Pfizer
Completed
NCT01390519 2016-01-13
OSAT
Novartis
Completed
NCT02023359 2015-12-29
Danish Observational Study of Everolimus Plus Exemestane in Hormone Receptor (HR) Positive, Human Epidermal Growth Factor 2 (HER2) - Metastatic Breast Cancer
Novartis
Completed